Decreased zinc and downregulation of ZIP3 zinc uptake transporter in the development of pancreatic adenocarcinoma

Cancer Biology and Therapy

Volumn 12, Issue 4, 2011, Pages 297-303

  Costello, Leslie C ^a,b   Levy, Bernard A ^a   Desouki, Mohamed M ^c   Zou, Jing ^a   Bagasra, Omar ^d   Johnson, Leslie A ^d   Hanna, Nader ^a,b   Franklin, Renty B ^a  

^a UNIVERSITY OF MARYLAND DENTAL SCHOOL   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d CLAFLIN UNIVERSITY   (United States)

Author keywords

Acinar epithelium; Ductal epithelium; Panc 1 cells; Pancreatic adenocarcinoma; RREB 1; Zinc changes; Zinc inhibition cell growth; ZIP3 transporter

Indexed keywords

RREB1 PROTEIN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; ZINC; ZINC TRANSPORTER; ZIP1 PROTEIN; ZIP2 PROTEIN; ZIP3 PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PANCREAS; PANCREAS ADENOCARCINOMA; PANCREAS DUCT; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; CARCINOMA, PANCREATIC DUCTAL; CATION TRANSPORT PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DITHIZONE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; EPITHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; PANCREAS; PANCREATIC NEOPLASMS; QUINOLONES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS; TOSYL COMPOUNDS; TRANSCRIPTION FACTORS; ZINC;

EID: 84860389554     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.12.4.16356     Document Type: Article

References (36)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics 2009. CA Cancer J Clin 2009; 59:225-249
2. Costello L.C., Franklin RB The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots Mol Canc 2006; DOI: 10.1186/1476-4598-5-17.
3. Franklin R.B., Milon B., Feng P., Costello L.C. Zinc and zinc transporter in normal prostate function and the pathogenesis of prostate cancer. Front Biosci 2005; 10:2230-2239 (Pubitemid 40905294)
4. Franklin R.B., Costello L.C. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch Biochem Biophys 1970; 463:211-217
5. Danielsen A., Steinnes E. A study of some selected trace elements in normal and cancerous tissue by neutron activation analysis. J Nucl Med 1970; 11:260-264
6. Li M., Zhang Y., Liu Z., Bharadwaj U., Wang H., Wang X., et al. Aberrant expression of zinc transporter ZIP4 (SLC39A4) significantly contributes to human pancreatic cancer pathogenesis and progression. Proc Natl Acad Sci USA 2007; 104:18636-18641 (Pubitemid 350210749)
7. Lipman T.O., Diamond A., Mellow M.H., Patterson K.Y. Esophageal zinc content in human squamous esophageal cancer. J Am Coll Nutr 1987; 6:41-46 (Pubitemid 18053365)
8. Thiagalingam A., De Bustros A., Borges M., Jasti R., Compton D., Diamond L., et al. RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol 1996; 16:5335-5345 (Pubitemid 26315052)
9. Fujimoto-Nishiyama A., Ishii S., Matsuda S., Inoue J., Yamamoto T. A novel zinc finger protein, Finb, is a transcriptional activator and localized in nuclear bodies. Gene 1997; 195:267-275 (Pubitemid 27354704)
10. Liu H., Hew H.C., Lu Z.G., Yamaguchi T., Miki Y., Yoshida K. DNA damage signalling recruits RREB-1 to the p53 tumour suppressor promoter. Biochem J 2009; 422:543-551
11. Jiang W., Sequeira J.M., Nakayama Y., Lai S.C., Quadros E.V. Characterization of the promotor region of TCblR/CD320 gene, the receptor for cellular uptake of transcobalamin-bound cobalamin. Gene 2010; 15:49-55.
12. Mukhopadhyay N.K., Cinar B., Mukhopadhyay L., Lutchman M., Ferdinand A.S., Kim J., et al. The zinc finger protein ras-responsive element binding protein-1 is a coregulator of the androgen receptor: Implications for the role of the Ras pathway in enhancing androgenic signaling in prostate cancer. Mol Endocrinol 2007; 21:2056-2070 (Pubitemid 47347373)
13. Flajollet S., Poras L., Carosella E.D., Moreau P. RREB-1 Is a Transcriptional Repressor of HLA-G. J Immunol 2009; 183:6948-6959
14. Oxford G., Smith S.C., Hampton G., Theodorescu D. Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector. Oncogene 2007; 26:7143-7152 (Pubitemid 350059679)
15. Desouki M.M., Geradts J., Milon B., Franklin R.B., Costello L.C. hZip2 and hZip3 zinc transporters are downregulated in human prostate adenocarcinomatous glands. Mol Cancer 2007; 6:37.
16. Li M., Zhang Y., Bharadwaj U., Zhai Q.J., Ahern C.H., Fisher W.E., et al. Downregulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts. Clin Cancer Res 2009; 15:5993-6001.
17. Feng P., Liang J.Y., Li T.L., Guan Z.X., Zou J., Franklin R.B., et al. Zinc induces mitochondria apoptogenesis in prostate cells. Mol Urol 2000; 4:31-36 (Pubitemid 30238686)
18. Feng P., Li T.L., Guan Z.X., Franklin R.B., Costello L.C. Direct effect of zinc on mitochondrial apoptogenesis in prostate cells. Prostate 2002; 52:311-318
19. Feng P., Li T.L., Guan Z.X., Franklin R.B., Costello L.C. Effect of zinc on prostatic tumorigenicity in nude mice. Ann NY Acad Sci 2003; 1010:316-320 (Pubitemid 38264997)
20. Feng P., Li T., Guan Z., Franklin R.B., Costello LC The involvement of Bax in zinc-induced mitochondrial apoptogenesis in malignant prostate cells Mol Canc 2008; DOI: 10.1186/1476-4598-7-25.
21. Huang L., Kirschke C.P., Zhang Y Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression Canc Cell Int 2006; 31;6:10. DOI: 10.1186/1475-2867-6-10.
22. Uzzo R.G., Leavis P., Hatch W., Gabai V.L., Dulin N., Zvartau N., et al. Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents. Clin Cancer Res 2002; 8:3579-3583 (Pubitemid 35340736)
23. Golovine K., Makhov P., Uzzo R.G., Shaw T., Kunkle D., Kolenko V.M. Overexpression of the zinc uptake transporter hZIP1 inhibits nuclear factor-kappaB and reduces the malignant potential of prostate cancer cells in vitro and in vivo. Clin Cancer Res 2008; 14:5376-5384
24. Ishii K., Otsuka T., Iguchi K., Usui S., Yamamoto H., Sugimura Y., et al. Evidence that the prostate-specific antigen (PSA)/Zn2+ axis may play a role in human prostate cancer cell invasion. Cancer Lett 2004; 207:79-87.
25. Ishii K., Usui S., Sugimura Y., Yoshida S., Hioki T., Tatematsu M., et al. Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion. Int J Cancer 2001; 92:49-54. (Pubitemid 32187031)
26. Uzzo R.G., Crispen P.L., Golovine K., Makhov P., Horwitz E.M., Kolenko V.M. Diverse effects of zinc on NFkappaB and AP-1 transcription factors: Implications for prostate cancer progression. Carcinogenesis 2006; 10:1980-1990 (Pubitemid 44530572)
27. Donadelli M., Dalla P.E., Costanzo C., Scupoli M.T., Scarpa A., Palmieri M. Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. J Cell Biochem 2008; 104:202-212
28. Donadelli M., Dalla P.E., Scupoli M.T., Costanzo C., Scarpa A., Palmieri M Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis Biochim Biophys Acta 2009; 1793:273-80.
29. Zhu L., Shi G., Schmidt C.M., Hruban R.H., Konieczny S.F. Acinar cells contribute to the molecular heterogeneity of pancreatic intraepithelial neoplasia. Am J Pathol 2007; 171:263-273 (Pubitemid 47339243)
30. Shi C., Hong S.M., Lim P., Kamiyama H., Khan M., Anders R.A., et al. KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: Implications for the human pancreatic cancer cell of origin. Mol Cancer Res 2009; 7:230-236
31. Parsa I., Longnecker D.S., Scarpelli D.G., Pour P., Reddy J.K., Lefkowitz M. Ductal metaplasia of human exocrine pancreas and its association with carcinoma. Cancer Res 1985; 45:1285-1290 (Pubitemid 15111293)
32. Johnson L.A., Kanak M.A., Kajdacsy-Balla A., Pestaner J.P., Bagasra O. Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands. Methods 2010; 52:316-321
33. Cortesi M., Fridman E., Volkov A., Shilstein S.S.h., Chechik R., Breskin A., et al. Clinical assessment of the cancer diagnostic value of prostatic zinc: A comprehensive needle-biopsy study. Prostate 2008; 68:994-1006. (Pubitemid 351794164)
34. Franklin R.B., Feng P., Milon B., Desouki M.M., Singh K.K., Kajdacsy-Balla A., et al. hZIP1 zinc uptake transporter downregulation and zinc depletion in prostate cancer. Mol Cancer 2005; 4:32.
35. Sternberg S.S., Philips F.S. Histochemical demonstration of zinc in the dorsolateral prostate of the rat: Studies with oxine and dithizone. Am J Pathol 1965; 47:325-337
36. Bagasra O. Protocols for the in situ PCR-amplification and detection of mRNA and DNA sequences. Nat Protoc 2007; 2:2782-2795